83,95 €
83,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
42 °P sammeln
83,95 €
83,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
42 °P sammeln
Als Download kaufen
83,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
42 °P sammeln
Jetzt verschenken
83,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
42 °P sammeln
  • Format: ePub

Practical Radiobiology for Proton Therapy Planning covers the principles, advantages and potential pitfalls that occur in proton therapy, especially its radiobiological modelling applications. This book is intended to educate, inform and to stimulate further research questions. Additionally, it will help proton therapy centres when designing new treatments or when unintended errors or delays occur. The clear descriptions of useful equations for high LET particle beam applications, worked examples of many important clinical situations, and discussion of how proton therapy may be optimized are…mehr

Produktbeschreibung
Practical Radiobiology for Proton Therapy Planning covers the principles, advantages and potential pitfalls that occur in proton therapy, especially its radiobiological modelling applications. This book is intended to educate, inform and to stimulate further research questions. Additionally, it will help proton therapy centres when designing new treatments or when unintended errors or delays occur. The clear descriptions of useful equations for high LET particle beam applications, worked examples of many important clinical situations, and discussion of how proton therapy may be optimized are all important features of the text. This important book blends the relevant physics, biology and medical aspects of this multidisciplinary subject.


Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, D ausgeliefert werden.

Autorenporträt
Bleddyn Jones is Professor of Clinical Radiation Biology at the new Gray Institute for Radiation Oncology and Biology at the University of Oxford, as well as Honorary Consultant in Clinical Oncology, Oxford Radcliffe Hospitals NHS Trust. Over the past 20 years he has been involved with selection and referral of patients abroad for particle therapy. Present research interests include development of new accelerator technology, better prediction of the biological effects of different qualities of radiation and the role of fractionation in particle beam therapy. He is Deputy Director of the Oxford Master of Science course in Radiation Biology and Co-Director of the new Particle Therapy Cancer Research Institute.